The CEO of the company that makes Tylenol met privately with Secretary of Health and Human Services Robert F. Kennedy Jr. to ask him not to link the drug to autism.

Kirk Perry, chief executive of Kenvue, met with Kennedy over the active ingredient, acetaminophen, also known as paracetamol, which is essential in the efficacy of the pain-relieving pill, according to a Friday Wall Street Journal report.

The Kennedy-helmed agency plans to release the report within the month, according to an article last week from the Journal. As of Friday, the company saw more than $2.2 billion erased from its market cap following the news, according to data on Google Finance.

Perry serves as the New Jersey company’s interim CEO, which was spun off from Johnson & Johnson in 2023. Perry, along with Chief S

See Full Page